Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma

Published:2017-04-12 Issue:6 Volume:115 Page:752-759
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Kim Seung Hyun¹^ORCID,Shin Kyoo‐Ho¹,Moon Seong‐Hwan¹,Kong Youngho¹,Suh Jin‐Suck²,Yang Woo‐Ick³

Affiliation:

1. Department of Orthopaedic SurgeryYonsei University College of MedicineSeoulKorea

2. Department of Radiology and Research Institute of Radiological ScienceYonsei University College of MedicineSeoulKorea

3. Department of PathologyYonsei University College of MedicineSeoulKorea

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.24571

Reference36 articles.

1. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

2. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

3. Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity

4. Neoadjuvant chemotherapy for osteosarcoma of the extremity

5. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF;Virchows Archiv;2024-05-15

2. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma;Journal of Cellular and Molecular Medicine;2020-08-21

3. Targeting minimal residual disease: a path to cure?;Nature Reviews Cancer;2018-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3